Antihypertensive Therapy by ACEI/ARB Is Associated With Intestinal Flora Alterations and Metabolomic Profiles in Hypertensive Patients.

ACEI/ARB anti-hypertensive hypertension intestinal flora metabolomics

Journal

Frontiers in cell and developmental biology
ISSN: 2296-634X
Titre abrégé: Front Cell Dev Biol
Pays: Switzerland
ID NLM: 101630250

Informations de publication

Date de publication:
2022
Historique:
received: 25 01 2022
accepted: 28 02 2022
entrez: 11 4 2022
pubmed: 12 4 2022
medline: 12 4 2022
Statut: epublish

Résumé

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers (ACEI/ARB) are the first-line drugs for the treatment of essential hypertension (HTN), one of the most important risk factors for cardiovascular and cerebrovascular diseases. Intestinal flora and microbial metabolites have been demonstrated to play important roles in blood pressure (BP) regulation and HTN development. However, it remains elusive that intestinal bacteria and metabolites are associated with the protective effects of ACEI/ARB anti-hypertensive drugs against HTN. In this study, we evaluated the effect of ACEI/ARB on gut microbiome and metabolites in patients suffering from HTN. We performed 16S rRNA sequencing and fecal metabolomic analysis of 36 HTN patients placed on ACEI/ARB therapy and 19 newly diagnosed HTN patients with no history of anti-hypertensive treatment. Patients under medication treatment were further classified into well-controlled (

Identifiants

pubmed: 35399511
doi: 10.3389/fcell.2022.861829
pii: 861829
pmc: PMC8986158
doi:

Types de publication

Journal Article

Langues

eng

Pagination

861829

Informations de copyright

Copyright © 2022 Dong, Wang, Jiao, Yang, Chen and Li.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Clin Nutr ESPEN. 2021 Aug;44:78-84
pubmed: 34330516
Nat Rev Microbiol. 2017 Jul;15(7):384
pubmed: 28579608
Theranostics. 2021 Mar 31;11(12):5778-5793
pubmed: 33897881
Expert Rev Anti Infect Ther. 2013 Mar;11(3):297-308
pubmed: 23458769
Brain Behav Immun. 2020 Mar;85:120-127
pubmed: 31255682
Nature. 2021 Sep;597(7877):533-538
pubmed: 34497420
Br J Nutr. 2001 Mar;85(3):333-41
pubmed: 11299079
Biomed Pharmacother. 2019 Aug;116:109040
pubmed: 31170664
Dose Response. 2021 Apr 30;19(2):15593258211011342
pubmed: 33994888
Hypertension. 2020 Nov;76(5):1545-1554
pubmed: 32921194
Menopause. 2011 Jan;18(1):102-4
pubmed: 20811299
Stand Genomic Sci. 2011 Apr 29;4(2):200-9
pubmed: 21677857
Eur J Clin Nutr. 2005 Mar;59(3):456-8
pubmed: 15536472
Protein Cell. 2021 May;12(5):346-359
pubmed: 32989686
Nat Commun. 2020 Jan 17;11(1):362
pubmed: 31953381
Physiol Genomics. 2015 Jun;47(6):187-97
pubmed: 25829393
Microorganisms. 2019 Sep 26;7(10):
pubmed: 31561625
Clin Rheumatol. 2007 Mar;26(3):289-97
pubmed: 16941202
Carbohydr Polym. 2020 Nov 15;248:116780
pubmed: 32919569
Br J Pharmacol. 2020 Mar;177(5):1131-1149
pubmed: 31705533
Cell Host Microbe. 2015 May 13;17(5):690-703
pubmed: 25974306
Front Microbiol. 2020 Jun 24;11:1256
pubmed: 32670220
Microbiome. 2017 Feb 1;5(1):14
pubmed: 28143587
Cell Host Microbe. 2010 Sep 16;8(3):292-300
pubmed: 20833380
Gastroenterology. 2020 Sep;159(3):1170-1172.e1
pubmed: 32422208
Gut. 2016 May;65(5):749-56
pubmed: 26719299
Eur J Endocrinol. 2012 Apr;166(4):703-10
pubmed: 22223702
Clin Sci (Lond). 2020 Jan 31;134(2):289-302
pubmed: 31961431
Am J Hypertens. 2014 Feb;27(2):252-9
pubmed: 24108862
Circulation. 2018 Oct 23;138(17):e426-e483
pubmed: 30354655
Hypertension. 2019 Oct;74(4):1005-1013
pubmed: 31352822
Am J Clin Nutr. 2011 Jan;93(1):127-42
pubmed: 20980488
Hypertension. 2016 Oct;68(4):974-81
pubmed: 27528065
Eur Rev Med Pharmacol Sci. 2009 Mar-Apr;13(2):105-10
pubmed: 19499845
Gut. 2016 May;65(5):740-8
pubmed: 26657899
Hypertension. 2021 Feb;77(2):706-717
pubmed: 33342240
Am J Clin Nutr. 2017 Jun;105(6):1544-1551
pubmed: 28424190
Obesity (Silver Spring). 2011 Dec;19(12):2404-10
pubmed: 21779090
Am J Clin Nutr. 2014 Dec;100(6):1532-40
pubmed: 25411288
Zhonghua Xin Xue Guan Bing Za Zhi. 2011 Jul;39(7):579-615
pubmed: 22088239
Hypertension. 2020 Sep;76(3):968-975
pubmed: 32623923
Am J Clin Nutr. 2010 Jul;92(1):194-202
pubmed: 20484449
PLoS One. 2013 Sep 12;8(9):e74487
pubmed: 24069314
Front Cell Infect Microbiol. 2017 Aug 24;7:381
pubmed: 28884091
Genome Biol. 2012 Apr 16;13(9):R79
pubmed: 23013615
J Hypertens. 2018 Oct;36(10):1953-2041
pubmed: 30234752
Front Microbiol. 2021 Nov 04;12:719599
pubmed: 34803940
Nature. 2021 Dec;600(7887):110-115
pubmed: 34819672
Int J Syst Evol Microbiol. 2010 Jun;60(Pt 6):1296-1302
pubmed: 19667375
J Am Heart Assoc. 2019 Feb 19;8(4):e011704
pubmed: 30755057

Auteurs

Ying Dong (Y)

Heart Center and Beijing Key Laboratory of Hypertension, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.

Pan Wang (P)

Heart Center and Beijing Key Laboratory of Hypertension, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.

Jie Jiao (J)

Heart Center and Beijing Key Laboratory of Hypertension, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.

Xinchun Yang (X)

Heart Center and Beijing Key Laboratory of Hypertension, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.

Mulei Chen (M)

Heart Center and Beijing Key Laboratory of Hypertension, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.

Jing Li (J)

Heart Center and Beijing Key Laboratory of Hypertension, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.

Classifications MeSH